WallStreetZenWallStreetZen

NASDAQ: SEPN
Septerna Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SEPN

Based on 3 analysts offering 12 month price targets for Septerna Inc

Min Forecast
$18.00+41.18%
Avg Forecast
$23.00+80.39%
Max Forecast
$26.00+103.92%

Should I buy or sell SEPN stock?

Based on 3 analysts offering ratings for Septerna Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SEPN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates SEPN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SEPN stock forecasts and price targets.

SEPN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-23
lockedlocked$00.00+00.00%2025-05-16
lockedlocked$00.00+00.00%2025-05-16

1 of 1

Forecast return on equity

Is SEPN forecast to generate an efficient return?

Company
-36.85%
Industry
90.83%
Market
67.4%
SEPN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SEPN forecast to generate an efficient return on assets?

Company
-33.98%
Industry
25.61%
SEPN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SEPN earnings per share forecast

What is SEPN's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.12
Avg 2 year Forecast
-$2.00
Avg 3 year Forecast
-$3.31

SEPN revenue forecast

What is SEPN's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$104.2M
Avg 2 year Forecast
$62.5M
Avg 3 year Forecast
$50.0M

SEPN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SEPN$12.75$23.00+80.39%Buy
FTRE$6.36$5.50-13.52%Sell
RAPP$15.42$28.00+81.58%Buy
TSHA$2.62$8.17+211.72%Strong Buy
TRML$22.69$55.25+143.50%Strong Buy
View Top Biotech Stocks

Septerna Stock Forecast FAQ

Is Septerna Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SEPN) stock is to Buy SEPN stock.

Out of 3 analysts, 1 (33.33%) are recommending SEPN as a Strong Buy, 1 (33.33%) are recommending SEPN as a Buy, 1 (33.33%) are recommending SEPN as a Hold, 0 (0%) are recommending SEPN as a Sell, and 0 (0%) are recommending SEPN as a Strong Sell.

If you're new to stock investing, here's how to buy Septerna stock.

What is SEPN's earnings growth forecast for 2025-2027?

(NASDAQ: SEPN) Septerna's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.3%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.94%.

Septerna's earnings in 2025 is N/A.On average, 3 Wall Street analysts forecast SEPN's earnings for 2025 to be -$5,347,001, with the lowest SEPN earnings forecast at -$54,806,756, and the highest SEPN earnings forecast at $45,003,921. On average, 4 Wall Street analysts forecast SEPN's earnings for 2026 to be -$89,116,676, with the lowest SEPN earnings forecast at -$109,613,511, and the highest SEPN earnings forecast at -$67,728,674.

In 2027, SEPN is forecast to generate -$147,488,099 in earnings, with the lowest earnings forecast at -$147,488,099 and the highest earnings forecast at -$147,488,099.

What is SEPN's revenue growth forecast for 2025-2027?

(NASDAQ: SEPN) Septerna's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 142.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.88%.

Septerna's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast SEPN's revenue for 2025 to be $4,643,869,986, with the lowest SEPN revenue forecast at $3,262,561,508, and the highest SEPN revenue forecast at $6,025,178,464. On average, 2 Wall Street analysts forecast SEPN's revenue for 2026 to be $2,784,896,125, with the lowest SEPN revenue forecast at $1,336,750,140, and the highest SEPN revenue forecast at $4,233,042,110.

In 2027, SEPN is forecast to generate $2,227,916,900 in revenue, with the lowest revenue forecast at $2,227,916,900 and the highest revenue forecast at $2,227,916,900.

What is SEPN's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: SEPN) forecast ROA is -33.98%, which is lower than the forecast US Biotechnology industry average of 25.61%.

What is SEPN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SEPN price target, the average SEPN price target is $23.00, with the highest SEPN stock price forecast at $26.00 and the lowest SEPN stock price forecast at $18.00.

On average, Wall Street analysts predict that Septerna's share price could reach $23.00 by Jun 23, 2026. The average Septerna stock price prediction forecasts a potential upside of 80.39% from the current SEPN share price of $12.75.

What is SEPN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SEPN) Septerna's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that SEPN's EPS will be -$0.12 for 2025, with the lowest EPS forecast at -$1.23, and the highest EPS forecast at $1.01. On average, analysts forecast that SEPN's EPS will be -$2.00 for 2026, with the lowest EPS forecast at -$2.46, and the highest EPS forecast at -$1.52. In 2027, SEPN's EPS is forecast to hit -$3.31 (min: -$3.31, max: -$3.31).

What is SEPN's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: SEPN) forecast ROE is -36.85%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.